Pulmicort and Jakafi drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pulmicort (budesonide) and Jakafi (ruxolitinib phosphate). Common drug interactions include cerebrovascular accident among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Pulmicort and Jakafi. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

What is Jakafi?

Jakafi has active ingredients of ruxolitinib phosphate. It is often used in primary myelofibrosis. eHealthMe is studying from 56,530 Jakafi users. Check the latest studies of Jakafi.

On Jul, 05, 2026

33 people who take Pulmicort and Jakafi together, and have interactions are studied.

What are the common drug interactions of Pulmicort and Jakafi, by gender? *:

female:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Platelet count increased
Anaemia (lack of blood)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
Fatigue (feeling of tiredness)
Hypersplenism (enlarged spleen and a decrease in one or more types of blood cells)
Platelet count decreased

male:

Asthenia (weakness)
Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
Lung infection
White blood cell count increased
Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Confusional state
Fall
Fatigue (feeling of tiredness)
Headache (pain in head)

What are the common drug interactions of Pulmicort and Jakafi, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Abdominal discomfort
Fatigue (feeling of tiredness)
Headache (pain in head)

40-49:

n/a

50-59:

Death
Fall

60+:

Asthenia (weakness)
Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
Leukocytosis (increased white blood cells)
Lower respiratory tract infection
Lung infection
White blood cell count increased
Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
Diarrhoea
Drug ineffective
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)

What are the existing conditions these people have? *

Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 11 people, 33.33%
Glaucoma (increased fluid pressure in the eye with vision loss): 4 people, 12.12%
Sleep Disorder: 3 people, 9.09%
Canker Sores (painful, open sore in the mouth): 3 people, 9.09%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 9.09%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 6.06%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 6.06%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmicort and Jakafi?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously